The Discounted Cash Flow (DCF) valuation of Austar Lifesciences Ltd (6118.HK) is 2.19 HKD. With the latest stock price at 0.69 HKD, the upside of Austar Lifesciences Ltd based on DCF is 217.6%.
Based on the latest price of 0.69 HKD and our DCF valuation, Austar Lifesciences Ltd (6118.HK) is a buy. buying 6118.HK stocks now will result in a potential gain of 217.6%.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 8.5% | 7.2% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 1.23 - 6.48 | 2.19 |
| Upside | 78.6% - 838.9% | 217.6% |